639520-10-8

Basic information

• Product Name: Cyclopentanepropanoic acid, 1-methyl-a-[[(phenylmethoxy)carbonyl]amino]-, methyl ester
• CAS NO: 639520-10-8
• Molecular Formula: C18H25NO4
• Molecular Weight: 319.401
• Mol File: 639520-10-8.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Cyclopentanepropanoic acid, 1-methyl-a-[[(phenylmethoxy)carbonyl]amino]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclopentanepropanoic acid, 1-methyl-a-[[(phenylmethoxy)carbonyl]amino]-, methyl ester(639520-10-8)
• EPA Substance Registry System: Cyclopentanepropanoic acid, 1-methyl-a-[[(phenylmethoxy)carbonyl]amino]-, methyl ester(639520-10-8)

Safety Data

• Hazardous Substances Data: 639520-10-8(Hazardous Substances Data)

Upstream product

• 19872-99-2 1-bromo-1-methyl-cyclopentane 
• 21149-17-7 methyl 2-(benzyloxycarbonylamino)acrylate 
• 39692-63-2 2-benzyloxycarbonylamino-acrylic acid 

Downstream Products

• 849093-81-8 (S)-2-benzyloxycarbonylamino-3-(1-methylcyclopentyl)-propionic acid methyl ester 
• 639520-11-9 (R)-2-benzyloxycarbonylamino-3-(1-methylcyclopentyl)-propionic acid methyl ester 
• 639520-12-0 (S)-2-benzyloxycarbonylamino-3-(1-methylcyclopentyl)propionic acid 

Relevant articles and documents

PROCESSES AND INTERMEDIATES FOR PREPARING CYSTEINE PROTEASE INHIBITORS

The present invention is directed to a novel process for preparing certain cysteine protease inhibitors.

AMIDINO COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS

The application is directed to haloalkyl-substituted compounds of Formula (I), wherein R1, R1a, R2, R3, R4’ and E are as defined in the claims. The compounds are inhibitors of cysteine proteases, in p